Introduction
The incidence of pulmonary embolism (PE) in Sweden has increased from 54 to 86/100,000 citizens between 2001 and 2011 (www.socialstyrelsen.se/statistikdatabas; accessed October 25, 2013) which is in line with European numbers and often attributed to the increased use of computed tomography for diagnosis. During the same period, development of surgical and radiological techniques, pumps and filters for extracorporeal support and medical (air) transportation, has resulted in nonpharmacological treatment emerging as an alternative for selected cases.
Acute PE with circulatory failure
In accordance with European 1 and American 2,3 guidelines the firstline treatment for acute PE with circulatory failure is IV thrombolysis. The main idea behind fibrinolytic therapy is to achieve a pharmacological fragmentation of fresh, centrally located thrombi so that they can disperse and resolve in the periphery of the lungs. If fibrinolysis is contraindicated or does not have sufficient effect, surgical embolectomy or catheter fragmentation by a radiologist are the next options. There are no studies indicating superiority of either procedure and both require resources and skills that are normally found only in tertiary centres in Sweden. Since they infer risk of PE recurrence during or after the procedures, especially if anticoagulation needs to be interrupted, insertion of an inferior vena caval filter is mandatory. In the case of surgical embolectomy, preoperative filter insertion consumes valuable time and sometimes needs to be omitted.
Radiological fragmentation of thrombi can be achieved using a variety of catheter designs, some of which include elimination of the detached material by suctioning as opposed to endogenous lysis after peripheral dispertion. 4 Swedish interventionists and X-ray laboratories are gradually acquiring this capacity with much of the introductory work done in Lund, where 8-12 patients are treated yearly. Surgical embolectomy, by its nature, is available only in thoracic surgery centres among which Stockholm, Lund and Gothenburg are the most prominent in Sweden. The Stockholm Department of Thoracic Surgery recently reported a total of 12 cases of embolectomy performed between 1957 and 1996 with only two deaths related to the hospitalisation for PE. 5 This could
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ECMO therapy
When massive PE causes severe circulatory failure or circulatory arrest, extracorporeal membrane oxygenation (ECMO) can restore and maintain adequate perfusion. 7 Once the circuit is established, additional investigations and review for further treatment can be undertaken. While surgical or radiological interventions are probable options, it has been observed that centrally located emboli may dissolve spontaneously during ECMO treatment with heparin. 8 The equipment is readily ambulant and can be applied to the patient in his/her present location, provided that the nearest thoracic surgery unit has the necessary resources to mobilise. In the patient at imminent risk of circulatory collapse and cardiac arrest, preparatory access to the femoral vein and artery can be achieved with small-bore catheters before the ECMO team arrives. If regional capacity is low, the Swedish ECMO centre in Stockholm, may also be asked to assist with on-ECMO transportation to the nearest thoracic facility.
Management algorithm
We recently introduced a comprehensive algorithm for the management of patients in circulatory failure due to massive PE (Figure 1 ). In line with other recent proposals, 9 it includes ECMO as a bridge to non-pharmacological treatment but also as a primary means of saving the patient in circulatory arrest, when PE can be judged probable. IV thrombolysis is the primary treatment but if it is contraindicated or unsuccessful and time is running out, interdisciplinary consultation is advocated to establish the basis of all further management. The following recent case from Gothenburg illustrates these aspects.
Case report
A 50-year-old male deficient of protein S and with earlier thromboembolism had developed ulcerative colitis and anticoagulant therapy had not been consistent due to recurrent bleeding. One month previously, he was diagnosed with acute and chronic PE that was successfully treated with tinzaparin under in-JICS supplement © The Intensive Care Society 2014 hospital supervision. The patient had been discharged with further injections prescribed but subsequently turned up in the emergency department short of breath. Vital signs were normal except pulse 118/min and respiratory rate 26/min and he complained about chest pain. Analysis of anti-Xa levels indicated that there had been compliance with the prescribed injections. Echocardiography revealed increased distension of the right ventricle compared to one week earlier and pulmonary arterial pressure had increased from 60 to 80 mm Hg. An interdisciplinary review deemed thrombolysis contraindicated and the patient was assigned to catheter fragmentation.
An inferior vena caval filter was installed and fresh thrombi in the left lung were successfully fragmented. However, the angiography revealed that the right lung was hardly perfused due to chronic thrombi adherent to the vessel walls. Pulmonary arterial pressure did not decrease postoperatively and IV epoprostenol and oral sildenafil were attempted, albeit unsuccessfully.
On the fourth day of re-hospitalisation, increased signs of right ventricular failure prompted thoracic surgery in an attempt to extract chronic and remaining fresh thrombi. It was successful although surgery was extended and failure of the right heart necessitated postoperative ECMO support. Unfortunately, pulmonary hypertension persisted due to peripheral chronic embolism that had gone too far and the patient succumbed. However, management illustrates that interdisciplinary consultation made all treatment options available to the patient.
Conclusion
The regional organisation of Swedish Healthcare affiliates every ICU to a tertiary centre where non-pharmacological treatment of acute massive PE can be initiated. If resources are not primarily available there, assistance can be expected to be offered from other regions when contacted. Long-haul transportation is coordinated on a national basis and can be mobilised quite readily. The main function of the proposed algorithm does not lie in medical advice but in its informative function as to possible use of these resources. We think that a few Swedish cases among patients with massive PE could be salvaged by better communication and interdisciplinary consultation between colleagues and hospitals involved in this chain of events. 
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